Information  X 
Enter a valid email address

N4 Pharma Plc Ord 0.4P (N4P)

Date Time Source Announcement
14 Feb 2019 2:14 pm
RNS
Holding(s) in Company
08 Feb 2019 12:23 pm
RNS
Placing to raise �1.05 million
20 Dec 2018 7:00 am
RNS
Nuvec licence extension
28 Nov 2018 7:00 am
RNS
Nuvec? research update
16 Nov 2018 1:36 pm
RNS
Nuvec resource changes
15 Nov 2018 7:00 am
RNS
Filing of further Nuvec? patent application
14 Nov 2018 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
08 Nov 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
05 Nov 2018 11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:00 am
RNS
Price Monitoring Extension
  7:54 am
RNS
Research collaboration update
29 Oct 2018 7:00 am
RNS
Nuvec? research update
02 Oct 2018 11:44 am
RNS
Research collaboration for novel DNA vaccine
26 Sep 2018 1:48 pm
RNS
Grant of options
  11:00 am
RNS
Price Monitoring Extension
24 Sep 2018 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Acceptance of Nuvec? on EUNCL
20 Sep 2018 7:01 am
RNS
Interim Results
  7:00 am
RNS
Strategic Review
30 Jul 2018 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Change of Adviser
17 Jul 2018 1:12 pm
RNS
Holding(s) in Company
11 Jul 2018 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
09 Jul 2018 7:00 am
RNS
Clinical trials preliminary results
18 Jun 2018 7:00 am
RNS
Nuvec? Update
23 May 2018 11:31 am
RNS
Result of AGM
09 May 2018 7:00 am
RNS
Filing of Patent
27 Apr 2018 11:00 am
RNS
Posting of Annual Report and Notice of AGM
25 Apr 2018 7:00 am
RNS
Final Results
18 Apr 2018 7:00 am
RNS
Commencement of Sildenafil Clinical Trial
09 Apr 2018 11:00 am
RNS
Price Monitoring Extension
09 Mar 2018 8:43 am
RNS
Exercise of Warrants and Total Voting Rights
08 Mar 2018 10:05 am
RNS
Holding(s) in Company
  7:00 am
RNS
Nuvec? Update
07 Mar 2018 8:33 am
RNS
Exercise of Warrants and Total Voting Rights
02 Mar 2018 12:17 pm
RNS
Change of Adviser
26 Feb 2018 9:27 am
RNS
Exercise of Warrants and Total Voting Rights
21 Feb 2018 1:36 pm
RNS
Exercise of Warrants and Total Voting Rights
19 Feb 2018 5:01 pm
RNS
Exercise of Warrants and Total Voting Rights
14 Feb 2018 5:26 pm
RNS
Exercise of Warrants and Total Voting Rights
13 Feb 2018 12:52 pm
RNS
Exercise of Warrants and Total Voting Rights
12 Feb 2018 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
08 Feb 2018 12:01 pm
RNS
Holding(s) in Company
  11:46 am
RNS
Exercise of Warrants and Total Voting Rights
05 Feb 2018 7:00 am
RNS
Issue of Equity and Director/PDMR Shareholding
 
Headlines
Top categories

22-Feb-2019 10:30 AM

Broker Forecast - UBS issues a broker note on GlaxoSmithKline PLC

UBS today downgrades its investment rating on GlaxoSmithKline PLC (LON:GSK) to neutral (from buy) and cut its price target to 1650p (from 1700p). St ...

Company finder

a d v e r t i s e m e n t